Clinical Trial of BPaMZ Regimen Will Replace Phase 3 STAND Trial
NEW YORK (21 December, 2016)—TB Alliance announced, based on positive results from the Phase 2b NC-005 trial, that it will
NEW YORK (21 December, 2016)—TB Alliance announced, based on positive results from the Phase 2b NC-005 trial, that it will
The government of Germany has announced its support for the development of new treatments to combat tuberculosis (TB). Germany’s Federal
October 27, 2016 (LIVERPOOL, ENGLAND) – TB Alliance, a non-profit organization dedicated to developing better and faster cures for tuberculosis (TB),
“The newly released global tuberculosis (TB) report from World Health Organization (WHO) is reporting the grim reality that more people are
27 September 2016 (Nairobi, Kenya) – TB Alliance is proud to announce the launch of new medicines for childhood tuberculosis
“TB Alliance welcomes the UN’s Political Declaration on Antimicrobial Resistance (AMR), which is an important step in mobilizing the political and
This piece first appeared at SciDev.Net. Access the original story here. MANILA (August 25, 2016) Several countries are in a race to make
NEW YORK AND OSAKA (June 21, 2016) — TB Alliance and Takeda Pharmaceutical Company Limited (Headquarters: Osaka, Japan; “Takeda”) announced
NEW YORK AND GENEVA (April 20, 2016) – TB Alliance and the Medicines Patent Pool (MPP) today announced a Memorandum
NEW YORK, NY (March 11, 2016)—TB Alliance has announced that it has stopped the clinical development program for the tuberculosis